Gilead Sciences Inc (GILD)
90.20
+0.36
(+0.40%)
USD |
NASDAQ |
Nov 05, 16:00
90.39
+0.19
(+0.21%)
After-Hours: 20:00
Gilead Sciences Price to Book Value: 6.143 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 6.118 |
| November 01, 2024 | 6.096 |
| October 31, 2024 | 6.049 |
| October 30, 2024 | 6.013 |
| October 29, 2024 | 5.998 |
| October 28, 2024 | 6.045 |
| October 25, 2024 | 6.061 |
| October 24, 2024 | 6.046 |
| October 23, 2024 | 5.941 |
| October 22, 2024 | 6.004 |
| October 21, 2024 | 5.877 |
| October 18, 2024 | 5.906 |
| October 17, 2024 | 5.950 |
| October 16, 2024 | 5.908 |
| October 15, 2024 | 5.845 |
| October 14, 2024 | 5.792 |
| October 11, 2024 | 5.785 |
| October 10, 2024 | 5.766 |
| October 09, 2024 | 5.866 |
| October 08, 2024 | 5.803 |
| October 07, 2024 | 5.750 |
| October 04, 2024 | 5.761 |
| October 03, 2024 | 5.732 |
| October 02, 2024 | 5.771 |
| October 01, 2024 | 5.717 |
| Date | Value |
|---|---|
| September 30, 2024 | 5.710 |
| September 27, 2024 | 5.694 |
| September 26, 2024 | 5.655 |
| September 25, 2024 | 5.599 |
| September 24, 2024 | 5.706 |
| September 23, 2024 | 5.72 |
| September 20, 2024 | 5.717 |
| September 19, 2024 | 5.714 |
| September 18, 2024 | 5.713 |
| September 17, 2024 | 5.656 |
| September 16, 2024 | 5.664 |
| September 13, 2024 | 5.640 |
| September 12, 2024 | 5.664 |
| September 11, 2024 | 5.512 |
| September 10, 2024 | 5.546 |
| September 09, 2024 | 5.392 |
| September 06, 2024 | 5.361 |
| September 05, 2024 | 5.364 |
| September 04, 2024 | 5.389 |
| September 03, 2024 | 5.428 |
| August 30, 2024 | 5.380 |
| August 29, 2024 | 5.411 |
| August 28, 2024 | 5.350 |
| August 27, 2024 | 5.244 |
| August 26, 2024 | 5.241 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.446
Minimum
Mar 10 2022
6.143
Maximum
Nov 05 2024
4.426
Average
4.404
Median
May 06 2020
Price to Book Value Benchmarks
| Merck & Co Inc | 5.912 |
| Eli Lilly and Co | 53.76 |
| Amgen Inc | 22.80 |
| Pfizer Inc | 1.808 |
| Bristol-Myers Squibb Co | 6.619 |
Price to Book Value Related Metrics
| PE Ratio | 110.00 |
| PS Ratio | 4.063 |
| Price to Free Cash Flow | 16.38 |
| Price | 90.20 |
| Earnings Yield | 0.91% |
| Market Cap | 112.30B |
| Operating PE Ratio | 15.67 |
| Normalized PE Ratio | 21.16 |